SK283883B6 - Použitie fumagillolu a jeho derivátov na prípravu liekov proti intestinálnym chorobám a farmaceutický prostriedok - Google Patents

Použitie fumagillolu a jeho derivátov na prípravu liekov proti intestinálnym chorobám a farmaceutický prostriedok Download PDF

Info

Publication number
SK283883B6
SK283883B6 SK1307-97A SK130797A SK283883B6 SK 283883 B6 SK283883 B6 SK 283883B6 SK 130797 A SK130797 A SK 130797A SK 283883 B6 SK283883 B6 SK 283883B6
Authority
SK
Slovakia
Prior art keywords
fumagillol
active ingredient
preparation
medicaments
milligrams
Prior art date
Application number
SK1307-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK130797A3 (en
Inventor
Jean-Michel Molina
Francis Derouin
Original Assignee
Sanofi-Synthelabo
Assistance Publique- Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo, Assistance Publique- Hopitaux De Paris filed Critical Sanofi-Synthelabo
Publication of SK130797A3 publication Critical patent/SK130797A3/sk
Publication of SK283883B6 publication Critical patent/SK283883B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
SK1307-97A 1995-03-27 1996-03-26 Použitie fumagillolu a jeho derivátov na prípravu liekov proti intestinálnym chorobám a farmaceutický prostriedok SK283883B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503549 1995-03-27
PCT/FR1996/000448 WO1996030010A2 (fr) 1995-03-27 1996-03-26 Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales

Publications (2)

Publication Number Publication Date
SK130797A3 SK130797A3 (en) 1998-03-04
SK283883B6 true SK283883B6 (sk) 2004-04-06

Family

ID=9477436

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1307-97A SK283883B6 (sk) 1995-03-27 1996-03-26 Použitie fumagillolu a jeho derivátov na prípravu liekov proti intestinálnym chorobám a farmaceutický prostriedok

Country Status (25)

Country Link
US (1) US5900431A (de)
EP (1) EP0817626B1 (de)
JP (1) JP3260378B2 (de)
KR (1) KR100286920B1 (de)
CN (1) CN1072485C (de)
AP (1) AP646A (de)
AT (1) ATE172641T1 (de)
AU (1) AU706161B2 (de)
CA (1) CA2216623C (de)
CZ (1) CZ286821B6 (de)
DE (1) DE69600879T2 (de)
DK (1) DK0817626T3 (de)
EA (1) EA000150B1 (de)
ES (1) ES2128846T3 (de)
FR (1) FR06C0014I2 (de)
HU (1) HU224028B1 (de)
IS (1) IS2048B (de)
NO (1) NO315968B1 (de)
NZ (1) NZ304906A (de)
OA (1) OA10515A (de)
PL (1) PL183378B1 (de)
SK (1) SK283883B6 (de)
TR (1) TR199701048T1 (de)
UA (1) UA41446C2 (de)
WO (1) WO1996030010A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100286920B1 (ko) * 1995-03-27 2001-04-16 디. 꼬쉬 장감염에 대한 약물제조용 푸마길올 및 그의 유도체의 용도
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat
DE60034770T2 (de) * 1999-02-26 2008-04-30 Sanofi-Aventis Stabile fumagillin-formulierung
JP3265394B1 (ja) * 2001-03-14 2002-03-11 泰三 矢野 アクリル系樹脂手袋
DE10341887A1 (de) * 2003-09-09 2005-03-31 Leopold Kostal Gmbh & Co. Kg Elektrisches Schaltermodul
FR2886855B1 (fr) * 2005-06-08 2009-07-17 Agronomique Inst Nat Rech Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques
CN101990441A (zh) * 2007-11-28 2011-03-23 默萨那治疗学股份有限公司 生物相容的生物可降解的烟曲霉素类似物轭合物
US8865746B2 (en) * 2008-07-18 2014-10-21 Zafgen, Inc. Methods of treating an overweight or obese subject
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
WO2010065877A2 (en) 2008-12-04 2010-06-10 Zafgen Corporation Methods of treating an overweight or obese subject
MX337575B (es) 2009-10-09 2016-03-10 Zafgen Corp Compuestos de sulfona y métodos para lafabricación y uso de éstos.
JP5827239B2 (ja) 2010-01-08 2015-12-02 ザフゲン，インコーポレイテッド フマギロール型化合物並びにその製造方法及び使用方法
WO2011085198A1 (en) 2010-01-08 2011-07-14 Zafgen Corporation Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
CA2806221A1 (en) 2010-07-22 2012-01-26 Zafgen, Inc. Tricyclic compounds and methods of making and using same
EP2638023B1 (de) 2010-11-09 2016-09-07 Zafgen, Inc. Crystalline feststoffe von einem metap-2-hemmer, verfahren zu deren herstellung und verwendung
MX2013005989A (es) 2010-11-29 2013-08-21 Zafgen Inc Tratamiento de obesidad utilizando administracion no diaria de 6-o-(4-dimetilaminoetoxi)cinamoil fumagilol.
US9321740B2 (en) 2011-01-26 2016-04-26 Zafgen, Inc. Tetrazole compounds and methods of making and using same
JP5876513B2 (ja) 2011-03-08 2016-03-02 ザフゲン，インコーポレイテッド オキサスピロ［２．５］オクタン誘導体および類似体
EA025526B1 (ru) 2011-05-06 2017-01-30 Зафджен Инк. Частично насыщенные трициклические соединения и способы их получения и применения
CN103748094B (zh) 2011-05-06 2016-06-29 扎夫根股份有限公司 三环磺酰胺化合物及其制备和使用方法
EP2705035B1 (de) 2011-05-06 2016-12-14 Zafgen, Inc. Tricyclische pyrazolsulfonamidverbindungen sowie verfahren und herstellung zu ihrer herstellung
EP2763671A2 (de) 2011-10-03 2014-08-13 Zafgen, Inc. Verfahren zur behandlung von altersbedingten erkrankungen
BR112014017780A8 (pt) 2012-01-18 2017-07-11 Zafgen Inc Compostos de sulfona tricíclicos e métodos para fazer e usar os mesmos
MX2014008706A (es) 2012-01-18 2015-03-05 Zafgen Inc Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
BR112014027808A2 (pt) 2012-05-07 2017-06-27 Zafgen Inc sal polimórfico do sal de oxalato de 6-o-(4-dimetilaminoetoxi) cinaroil fumagilol e métodos de produção e utilização do mesmo
WO2013169857A1 (en) 2012-05-08 2013-11-14 Zafgen, Inc. Treating hypothalamic obesity with metap2 inhibitors
CN104364251B (zh) 2012-05-09 2017-02-22 扎夫根股份有限公司 烟曲霉醇型化合物及其制备和使用方法
KR20150079951A (ko) 2012-11-05 2015-07-08 자프겐 인크. 간 질환의 치료 방법
MX2015005733A (es) 2012-11-05 2016-02-10 Zafgen Inc Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
CN104870433A (zh) 2012-11-05 2015-08-26 扎夫根股份有限公司 三环化合物及其制备方法和用途
AU2014236528A1 (en) 2013-03-14 2015-09-24 Zafgen, Inc. Methods of treating renal disease and other disorders
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106591389B (zh) * 2015-10-15 2019-10-11 中国科学院微生物研究所 一种利用烟曲霉菌生产烟曲霉素的方法
CN105622593B (zh) * 2016-02-25 2018-06-26 中国农业科学院蜜蜂研究所 一种烟曲霉素的提取方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2791530A (en) * 1953-08-31 1957-05-07 Abbott Lab Stabilized fumagillin compositions
JPH0629278B2 (ja) * 1985-06-26 1994-04-20 藤沢薬品工業株式会社 オキサスピロオクタン化合物
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
WO1992002240A2 (en) * 1990-07-27 1992-02-20 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
KR100286920B1 (ko) * 1995-03-27 2001-04-16 디. 꼬쉬 장감염에 대한 약물제조용 푸마길올 및 그의 유도체의 용도
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
AU3968597A (en) * 1996-08-02 1998-02-25 Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors

Also Published As

Publication number Publication date
AP646A (en) 1998-04-27
KR100286920B1 (ko) 2001-04-16
TR199701048T1 (xx) 1998-01-21
HUP9801220A2 (hu) 1999-09-28
PL183378B1 (pl) 2002-06-28
NO974466D0 (no) 1997-09-26
IS4557A (is) 1997-09-11
ATE172641T1 (de) 1998-11-15
OA10515A (fr) 2002-04-24
CA2216623C (en) 2005-05-31
EA199700267A1 (ru) 1998-04-30
FR06C0014I1 (de) 2006-11-17
JP3260378B2 (ja) 2002-02-25
EA000150B1 (ru) 1998-10-29
CA2216623A1 (en) 1996-10-03
CZ286821B6 (en) 2000-07-12
NO974466L (no) 1997-09-26
IS2048B (is) 2005-09-15
ES2128846T3 (es) 1999-05-16
CN1072485C (zh) 2001-10-10
US5900431A (en) 1999-05-04
HU224028B1 (hu) 2005-05-30
DK0817626T3 (da) 1999-07-12
KR19980703271A (ko) 1998-10-15
CZ304997A3 (en) 1997-12-17
NZ304906A (en) 1999-06-29
HUP9801220A3 (en) 2001-10-29
UA41446C2 (uk) 2001-09-17
EP0817626A2 (de) 1998-01-14
PL322470A1 (en) 1998-02-02
WO1996030010A2 (fr) 1996-10-03
FR06C0014I2 (de) 2006-12-29
SK130797A3 (en) 1998-03-04
DE69600879T2 (de) 1999-06-02
EP0817626B1 (de) 1998-10-28
WO1996030010A3 (fr) 1996-11-28
AU706161B2 (en) 1999-06-10
AU5278696A (en) 1996-10-16
NO315968B1 (no) 2003-11-24
MX9707150A (es) 1998-07-31
DE69600879D1 (de) 1998-12-03
AP9701092A0 (en) 1997-10-31
JPH11506421A (ja) 1999-06-08
CN1179715A (zh) 1998-04-22

Similar Documents

Publication Publication Date Title
SK283883B6 (sk) Použitie fumagillolu a jeho derivátov na prípravu liekov proti intestinálnym chorobám a farmaceutický prostriedok
RU2197233C2 (ru) Применение кислых алкилфумаратов для лечения псориаза, псориатического артрита, нейродермита и регионального энтерита крона
US7749987B2 (en) Contraception method
EP0264187A1 (de) Ibuprofen und Aluminiumhydroxid enthaltendes Arzneimittel
US4588589A (en) Antidiarrheal compositions and use thereof
DE3834794C2 (de)
EP1140082A1 (de) Kombination von cerivastatin und fibraten
CA2136977A1 (en) _-8-tetrahydro-cannabinol as antiemetic
IL126199A (en) Pharmaceutical preparation for administration through the nose for preventive treatment for delayed vomiting
US4064230A (en) Polyenic macrolide compositions
US4895851A (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
EP0003750B1 (de) Salze von Dithiodialkansulfonsäuren zur Verwendung bei der cytostatischen Therapie mit Alkylantien
GB2137089A (en) Pyrethroid-containing pharmaceutical compositions
EP0435926A1 (de) Gallensäuren zur behandlung von viralen infektionen
JPS6193119A (ja) 相乗効果性避妊薬組成物
MXPA97007150A (en) Use of fumagilol and its derivatives to prepare medicines intended to combat intestine infections
IE900306A1 (en) Agent for use in the prevention, control or reversal of¹hypertension
Chang et al. Activity of roxithromycin against Toxoplasma gondii in murine models
US4237159A (en) Novel anti-inflammatory composition
JPH0132804B2 (de)
FR2566664A1 (fr) Composition utile au traitement de la diarrhee contenant du dextromethorphan
JPS63258421A (ja) 糖ラクタムを含有する抗炎症剤
Romankiewicz Factors Influencing Renal Distribution of Antibiotics a Key to Therapy of Pyelonephritis

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20160326